Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ocugen, Inc. - Common Stock
(NQ:
OCGN
)
0.6794
+0.0262 (+4.01%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
33
34
Next >
7 Biotech Stocks to Sell in July
July 13, 2023
Running the gamut from large to small, and from commercial stage to clinical stage, these are seven top biotech stocks to sell in July.
Via
InvestorPlace
7 Doomed Growth Stocks Destined for Disaster
July 12, 2023
Investing in growth stocks can be very expensive. Save yourself some time and money by avoiding these doomed growth stocks to sell.
Via
InvestorPlace
Ocugen CEO & CSO to Present at 41st Annual AAPI Convention and Scientific Assembly
June 30, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
June 20, 2023
The Dow Jones closed lower by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested...
Via
Benzinga
Can Pat Toomey Save Ocugen (OCGN) Stock?
June 05, 2023
Shares of OCGN stock received a boost this morning following the addition of some high-profile names to Ocugen's advisory board.
Via
InvestorPlace
Ocugen (OCGN) Q1 2023 Earnings Call Transcript
May 05, 2023
OCGN earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Ocugen: Q1 Earnings Insights
May 05, 2023
Via
Benzinga
Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders
June 09, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. Announces Business Advisory Board
June 05, 2023
From
Ocugen
Via
GlobeNewswire
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
May 25, 2023
These companies haven't given up on the coronavirus vaccine market.
Via
The Motley Fool
5 Investors Betting Big on Ocugen (OCGN) Stock Right Now
May 24, 2023
Ocugen has been falling after announcing a new share offering. But that's not the only reason hedge funds are moving away from OCGN stock.
Via
InvestorPlace
Earnings Outlook For Ocugen
May 04, 2023
Via
Benzinga
Crude Oil Rises 2%; Kohl's Reports Surprise Q1 Profit
May 24, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 250 points on Wednesday. The Dow traded down 0.73% to 32,813.21 while the NASDAQ fell 0.77% to 12,463.32. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 24, 2023
Via
Benzinga
Nasdaq Down 1%; US Crude Oil Inventories Decline Last Week
May 24, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.72% to 32,816.38 while the NASDAQ fell 1.12% to 12,419.97. The...
Via
Benzinga
Why Is Apexigen (APGN) Stock Up 31% Today?
May 24, 2023
Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS).
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Down 22% Today?
May 24, 2023
Ocugen (OCGN) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares.
Via
InvestorPlace
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 24, 2023
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 24, 2023
Via
Benzinga
Ocugen, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock
May 24, 2023
From
Ocugen
Via
GlobeNewswire
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 24, 2023
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 24, 2023
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning!
Via
InvestorPlace
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
May 23, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Present at BIO International Convention 2023
May 23, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen Provides Business Update with First Quarter 2023 Financial Results
May 05, 2023
From
Ocugen
Via
GlobeNewswire
Ocugen to Host Conference Call on Friday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2023 Financial Results
April 28, 2023
From
Ocugen
Via
GlobeNewswire
Earnings Scheduled For May 5, 2023
May 05, 2023
Companies Reporting Before The Bell • CNH Industrial (NYSE:CNHI) is estimated to report quarterly earnings at $0.32 per share on revenue of $5.08 billion.
Via
Benzinga
Ocugen Announces OCU410ST Receives Orphan Drug Designation for Treatment of ABCA4-Associated Retinopathies
April 27, 2023
U.S. Food & Drug Administration (FDA) grants orphan drug designation to OCU410ST for the treatment of ABCA4-associated retinopathies including Stargardt, RP19 and CORD3
From
Ocugen
Via
GlobeNewswire
Ocugen, Inc. to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference
April 26, 2023
From
Ocugen
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Tuesday
April 25, 2023
Tuesday's session saw 286 companies set new 52-week lows.
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.